Garner Health closes $100M Series E at $2.74B valuation
What's the deal? Garner Health, a digital platform that uses AI to help patients find top-performing doctors, has closed a $100M Series E round led by Index Ventures. Existing backers Kleiner Perkins, Redpoint, Thrive, Sequoia, Founders Fund, and Kaiser Permanente VenturesDealroom has a profile for this one. Try Dealroom → also participated, bringing Garner's valuation to $2.74B.
The New York-based company works with nearly 800 employers — including USA TodayDealroom has a profile for this one. Try Dealroom →, Paylocity, and the University of Oklahoma — to steer employees toward higher-quality providers while cutting healthcare costs. Its gross annual recurring revenue is roughly $200M, having more than doubled for five consecutive years.
Why now? Employers are under mounting pressure to rein in healthcare spending, which remains one of the largest line items on corporate balance sheets. Garner says its customers see an average 12% reduction in annual healthcare spend.
The platform analyses billions of data points to identify providers that deliver the best outcomes, then aligns financial incentives so employees pay less when they choose those doctors. The model now covers more than 2.5 million members. Alongside the funding round, Garner also conducted a second tender offer for employees.
What could go wrong? Garner's value proposition hinges on its ability to accurately measure physician quality — a notoriously difficult problem. If its AI-driven rankings produce errors or miss important nuance, trust from employers, health systems, and patients could erode quickly.
The company also faces a crowded field. Established players in benefits navigation and healthcare analytics are investing heavily in similar capabilities, and large insurers could build competing tools in-house.
The signal: Now at late growth stage with ~$200M in gross ARR that has doubled annually for five consecutive years, Garner Health sits at the intersection of two powerful tailwinds: employer demand for measurable healthcare cost reduction and investor conviction in AI-driven quality transparency. Index Ventures leading a $100M round at a $2.74B valuation — backed by a syndicate that includes Sequoia, Kleiner Perkins, and Founders Fund — suggests top-tier funds see provider-quality analytics as a durable, defensible category rather than a feature that incumbents can easily replicate.
Read more: prnewswire.com
